DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zyprexa (Olanzapine) - Published Studies

 



Zyprexa Related Published Studies

Well-designed clinical trials related to Zyprexa (Olanzapine)

Olanzapine-Divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. [2009.09.22]

A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). [2009.08]

Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. [2009.08]

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study. [2009.08]

Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction? [2009.07]

Olanzapine compared to quetiapine in adolescents with a first psychotic episode. [2009.07]

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. [2009.07]

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. [2009.07]

Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial. [2009.06.19]

Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men. [2009.06]

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis. [2009.05]

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. [2009.05]

Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. [2009.05]

An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. [2009.04.01]

Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. [2009.04]

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone. [2009.04]

A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia. [2009.04]

Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. [2009.04]

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis. [2009.03.28]

A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia. [2009.03.15]

A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions. [2009.03]

[Pattern and evolution of the prescription of olanzapine during one year: Results of the cohort study ECOL] [2009.02]

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. [2009.02]

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. [2009.01]

Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial. [2009.01]

Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial. [2009.01]

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. [2009.01]

An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects. [2008.12.20]

Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. [2008.12.12]

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. [2008.12.01]

Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. [2008.12]

Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. [2008.12]

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. [2008.11]

Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. [2008.10]

Changes in neuropsychological functioning following treatment with risperidone, olanzapine, and conventional antipsychotic medications. [2008.10]

Shift from first generation antipsychotics to olanzapine may improve health-related quality of life of stable but residually symptomatic schizophrenic outpatients: a prospective, randomized study. [2008.09]

Strategies of treatment with olanzapine in schizophrenic patients during stable phase: results of a pilot study. [2008.09]

Olanzapine versus droperidol for the treatment of primary headache in the emergency department. [2008.09]

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study. [2008.08]

Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study. [2008.08]

A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine. [2008.07]

Assessment of strategies for switching patients from olanzapine to risperidone: a randomized, open-label, rater-blinded study. [2008.06.30]

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. [2008.06]

Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. [2008.06]

Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. [2008.06]

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study. [2008.05.30]

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. [2008.05]

Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. [2008.05]

Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia. [2008.05]

8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. [2008.05]

An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. [2008.05]

An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. [2008.04.29]

Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. [2008.04]

Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine. [2008.04]

Predicting antipsychotic drug response - replication and extension to six weeks in an international olanzapine study. [2008.04]

Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial. [2008.03.11]

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. [2008.03.01]

Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. [2008.03]

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. [2008.03]

Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. [2008.02.15]

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. [2008.02]

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia. [2008.02]

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. [2008.02]

A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels. [2008.02]

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naive population. [2008.02]

Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. [2008.01.31]

Olanzapine in the Treatment of Pathological Gambling: A Negative Randomized Placebo-Controlled Trial. [2008.01.30]

Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2008.01]

A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. [2008.01]

A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial. [2008.01]

Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. [2007.12]

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study. [2007.12]

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?-A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. [2007.12]

Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine. [2007.11]

Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study. [2007.11]

Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms. [2007.11]

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. [2007.11]

Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. [2007.10.27]

Olanzapine versus placebo in the treatment of adolescents with bipolar mania. [2007.10]

Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation. [2007.10]

Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. [2007.10]

Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. [2007.09]

Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa. [2007.08]

Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study. [2007.08]

Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial. [2007.07.25]

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. [2007.07]

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. [2007.07]

Olanzapine therapy in anorexia nervosa: psychobiological effects. [2007.07]

Dissociating medication effects from learning and practice effects in a neurocognitive study of schizophrenia: Olanzapine versus haloperidol. [2007.07]

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial. [2007.07]

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. [2007.07]

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. [2007.06]

Olanzapine versus lithium in the acute treatment of bipolar mania: A double-blind, randomized, controlled trial. [2007.05.23]

Olanzapine-induced weight gain in anorexia nervosa: involvement of leptin and ghrelin secretion? [2007.05]

Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. [2007.04]

The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study. [2007.03.30]

A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. [2007.03]

A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania. [2007.03]

Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin. [2007.03]

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. [2007.02.20]

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009